Skip to Main Content

SAN FRANCISCO — Not many investors had pegged the long-stagnant immunotherapy developer NantKwest as one of the big stock winners of this week.

But on Monday, the first day of the J.P. Morgan Healthcare Conference, the stock soared 91% after the company’s founder and CEO, Dr. Patrick Soon-Shiong, gave an unusual television interview. With characteristic showmanship, the biotech billionaire announced that one patient with pancreatic cancer saw a complete disease response after receiving five infusions of a treatment his companies are developing.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED